nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—Cladribine—multiple sclerosis	0.452	1	CrCtD
Adenosine—SLC28A3—Cladribine—multiple sclerosis	0.189	1	CbGbCtD
Adenosine—Pentostatin—Cladribine—multiple sclerosis	0.0448	0.151	CrCrCtD
Adenosine—Clofarabine—Cladribine—multiple sclerosis	0.0356	0.12	CrCrCtD
Adenosine—Regadenoson—Cladribine—multiple sclerosis	0.0356	0.12	CrCrCtD
Adenosine—Fludarabine—Cladribine—multiple sclerosis	0.0333	0.113	CrCrCtD
Adenosine—Nelarabine—Cladribine—multiple sclerosis	0.0314	0.106	CrCrCtD
Adenosine—Adenosine monophosphate—Cladribine—multiple sclerosis	0.0314	0.106	CrCrCtD
Adenosine—Azacitidine—Cladribine—multiple sclerosis	0.0282	0.0956	CrCrCtD
Adenosine—Vidarabine—Cladribine—multiple sclerosis	0.0282	0.0956	CrCrCtD
Adenosine—Decitabine—Cladribine—multiple sclerosis	0.0269	0.0911	CrCrCtD
Adenosine—ADORA1—nerve—multiple sclerosis	0.00115	0.116	CbGeAlD
Adenosine—S-Adenosylmethionine—SRM—multiple sclerosis	0.000961	0.367	CrCbGaD
Adenosine—ADK—retina—multiple sclerosis	0.000496	0.0499	CbGeAlD
Adenosine—Clofarabine—RRM1—multiple sclerosis	0.000412	0.157	CrCbGaD
Adenosine—Fludarabine—RRM1—multiple sclerosis	0.000399	0.152	CrCbGaD
Adenosine—ADORA2B—nervous system—multiple sclerosis	0.00036	0.0362	CbGeAlD
Adenosine—ADK—medulla oblongata—multiple sclerosis	0.000358	0.036	CbGeAlD
Adenosine—ADORA2A—spinal cord—multiple sclerosis	0.000356	0.0358	CbGeAlD
Adenosine—ADORA2B—central nervous system—multiple sclerosis	0.000347	0.0349	CbGeAlD
Adenosine—ADORA1—medulla oblongata—multiple sclerosis	0.000345	0.0346	CbGeAlD
Adenosine—ADORA2B—cerebellum—multiple sclerosis	0.000339	0.0341	CbGeAlD
Adenosine—ADA—nervous system—multiple sclerosis	0.00033	0.0331	CbGeAlD
Adenosine—ADK—midbrain—multiple sclerosis	0.000328	0.0329	CbGeAlD
Adenosine—ADK—spinal cord—multiple sclerosis	0.00032	0.0321	CbGeAlD
Adenosine—ADA—central nervous system—multiple sclerosis	0.000317	0.0319	CbGeAlD
Adenosine—ADORA1—midbrain—multiple sclerosis	0.000315	0.0317	CbGeAlD
Adenosine—ADORA1—spinal cord—multiple sclerosis	0.000307	0.0309	CbGeAlD
Adenosine—ADORA2A—nervous system—multiple sclerosis	0.0003	0.0301	CbGeAlD
Adenosine—Glucosamine—IFNG—multiple sclerosis	0.000298	0.114	CrCbGaD
Adenosine—ADORA2A—central nervous system—multiple sclerosis	0.000289	0.029	CbGeAlD
Adenosine—ADORA2A—cerebellum—multiple sclerosis	0.000282	0.0284	CbGeAlD
Adenosine—ADORA2B—brain—multiple sclerosis	0.000275	0.0277	CbGeAlD
Adenosine—ADK—nervous system—multiple sclerosis	0.000269	0.0271	CbGeAlD
Adenosine—DPP4—nervous system—multiple sclerosis	0.000261	0.0262	CbGeAlD
Adenosine—ADK—central nervous system—multiple sclerosis	0.000259	0.0261	CbGeAlD
Adenosine—ADORA1—nervous system—multiple sclerosis	0.000259	0.026	CbGeAlD
Adenosine—ADK—cerebellum—multiple sclerosis	0.000253	0.0255	CbGeAlD
Adenosine—ADA—brain—multiple sclerosis	0.000252	0.0253	CbGeAlD
Adenosine—DPP4—central nervous system—multiple sclerosis	0.000251	0.0253	CbGeAlD
Adenosine—ADORA1—central nervous system—multiple sclerosis	0.000249	0.0251	CbGeAlD
Adenosine—ADORA1—cerebellum—multiple sclerosis	0.000244	0.0245	CbGeAlD
Adenosine—Cladribine—RRM1—multiple sclerosis	0.000236	0.0902	CrCbGaD
Adenosine—ADORA2A—brain—multiple sclerosis	0.000229	0.023	CbGeAlD
Adenosine—ADK—brain—multiple sclerosis	0.000206	0.0207	CbGeAlD
Adenosine—DPP4—brain—multiple sclerosis	0.0002	0.0201	CbGeAlD
Adenosine—ADORA1—brain—multiple sclerosis	0.000198	0.0199	CbGeAlD
Adenosine—Glucosamine—MMP9—multiple sclerosis	0.00019	0.0725	CrCbGaD
Adenosine—Glucosamine—TNF—multiple sclerosis	0.000125	0.0476	CrCbGaD
Adenosine—Acute coronary syndrome—Prednisolone—multiple sclerosis	9.62e-05	0.00271	CcSEcCtD
Adenosine—Myocardial infarction—Prednisolone—multiple sclerosis	9.57e-05	0.00269	CcSEcCtD
Adenosine—Arrhythmia—Mitoxantrone—multiple sclerosis	9.54e-05	0.00269	CcSEcCtD
Adenosine—Cardiac failure—Prednisone—multiple sclerosis	9.43e-05	0.00266	CcSEcCtD
Adenosine—Urticaria—Cladribine—multiple sclerosis	9.17e-05	0.00258	CcSEcCtD
Adenosine—Dysgeusia—Mitoxantrone—multiple sclerosis	9.11e-05	0.00256	CcSEcCtD
Adenosine—Affect lability—Prednisone—multiple sclerosis	9.06e-05	0.00255	CcSEcCtD
Adenosine—Back pain—Mitoxantrone—multiple sclerosis	9e-05	0.00253	CcSEcCtD
Adenosine—Bradycardia—Prednisolone—multiple sclerosis	8.92e-05	0.00251	CcSEcCtD
Adenosine—Acute coronary syndrome—Triamcinolone—multiple sclerosis	8.85e-05	0.00249	CcSEcCtD
Adenosine—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	8.83e-05	0.00249	CcSEcCtD
Adenosine—Myocardial infarction—Triamcinolone—multiple sclerosis	8.8e-05	0.00248	CcSEcCtD
Adenosine—Myocardial infarction—Methylprednisolone—multiple sclerosis	8.78e-05	0.00247	CcSEcCtD
Adenosine—Hypotension—Azathioprine—multiple sclerosis	8.77e-05	0.00247	CcSEcCtD
Adenosine—Vision blurred—Mitoxantrone—multiple sclerosis	8.76e-05	0.00247	CcSEcCtD
Adenosine—Cardiac arrest—Prednisone—multiple sclerosis	8.75e-05	0.00246	CcSEcCtD
Adenosine—Mood swings—Prednisone—multiple sclerosis	8.72e-05	0.00246	CcSEcCtD
Adenosine—Sweating—Methylprednisolone—multiple sclerosis	8.59e-05	0.00242	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Azathioprine—multiple sclerosis	8.55e-05	0.00241	CcSEcCtD
Adenosine—Hypersensitivity—Cladribine—multiple sclerosis	8.51e-05	0.0024	CcSEcCtD
Adenosine—Asthenia—Cladribine—multiple sclerosis	8.28e-05	0.00233	CcSEcCtD
Adenosine—Bradycardia—Triamcinolone—multiple sclerosis	8.21e-05	0.00231	CcSEcCtD
Adenosine—Bradycardia—Methylprednisolone—multiple sclerosis	8.19e-05	0.0023	CcSEcCtD
Adenosine—Cough—Mitoxantrone—multiple sclerosis	8.12e-05	0.00228	CcSEcCtD
Adenosine—Convulsion—Mitoxantrone—multiple sclerosis	8.06e-05	0.00227	CcSEcCtD
Adenosine—Acute coronary syndrome—Dexamethasone—multiple sclerosis	8.03e-05	0.00226	CcSEcCtD
Adenosine—Acute coronary syndrome—Betamethasone—multiple sclerosis	8.03e-05	0.00226	CcSEcCtD
Adenosine—Hypertension—Mitoxantrone—multiple sclerosis	8.03e-05	0.00226	CcSEcCtD
Adenosine—Myocardial infarction—Betamethasone—multiple sclerosis	7.99e-05	0.00225	CcSEcCtD
Adenosine—Myocardial infarction—Dexamethasone—multiple sclerosis	7.99e-05	0.00225	CcSEcCtD
Adenosine—Chest pain—Mitoxantrone—multiple sclerosis	7.92e-05	0.00223	CcSEcCtD
Adenosine—Anxiety—Mitoxantrone—multiple sclerosis	7.89e-05	0.00222	CcSEcCtD
Adenosine—Cerebrovascular accident—Methotrexate—multiple sclerosis	7.85e-05	0.00221	CcSEcCtD
Adenosine—Arrhythmia—Prednisolone—multiple sclerosis	7.83e-05	0.0022	CcSEcCtD
Adenosine—Discomfort—Mitoxantrone—multiple sclerosis	7.82e-05	0.0022	CcSEcCtD
Adenosine—Dizziness—Cladribine—multiple sclerosis	7.64e-05	0.00215	CcSEcCtD
Adenosine—Anaphylactic shock—Mitoxantrone—multiple sclerosis	7.59e-05	0.00214	CcSEcCtD
Adenosine—Shock—Mitoxantrone—multiple sclerosis	7.47e-05	0.0021	CcSEcCtD
Adenosine—Cardiac disorder—Methylprednisolone—multiple sclerosis	7.46e-05	0.0021	CcSEcCtD
Adenosine—Bradycardia—Dexamethasone—multiple sclerosis	7.45e-05	0.0021	CcSEcCtD
Adenosine—Bradycardia—Betamethasone—multiple sclerosis	7.45e-05	0.0021	CcSEcCtD
Adenosine—Tachycardia—Mitoxantrone—multiple sclerosis	7.41e-05	0.00209	CcSEcCtD
Adenosine—Vomiting—Cladribine—multiple sclerosis	7.34e-05	0.00207	CcSEcCtD
Adenosine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	7.34e-05	0.00207	CcSEcCtD
Adenosine—Mood swings—Methotrexate—multiple sclerosis	7.29e-05	0.00205	CcSEcCtD
Adenosine—Rash—Cladribine—multiple sclerosis	7.28e-05	0.00205	CcSEcCtD
Adenosine—Dermatitis—Cladribine—multiple sclerosis	7.27e-05	0.00205	CcSEcCtD
Adenosine—Mediastinal disorder—Methylprednisolone—multiple sclerosis	7.25e-05	0.00204	CcSEcCtD
Adenosine—Headache—Cladribine—multiple sclerosis	7.23e-05	0.00204	CcSEcCtD
Adenosine—Arrhythmia—Triamcinolone—multiple sclerosis	7.2e-05	0.00203	CcSEcCtD
Adenosine—Vision blurred—Prednisolone—multiple sclerosis	7.19e-05	0.00202	CcSEcCtD
Adenosine—Arrhythmia—Methylprednisolone—multiple sclerosis	7.18e-05	0.00202	CcSEcCtD
Adenosine—Hypotension—Mitoxantrone—multiple sclerosis	7.09e-05	0.002	CcSEcCtD
Adenosine—Acute coronary syndrome—Prednisone—multiple sclerosis	6.99e-05	0.00197	CcSEcCtD
Adenosine—Angioedema—Prednisolone—multiple sclerosis	6.97e-05	0.00196	CcSEcCtD
Adenosine—Myocardial infarction—Prednisone—multiple sclerosis	6.95e-05	0.00196	CcSEcCtD
Adenosine—Hypersensitivity—Azathioprine—multiple sclerosis	6.92e-05	0.00195	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Mitoxantrone—multiple sclerosis	6.91e-05	0.00195	CcSEcCtD
Adenosine—Dysgeusia—Triamcinolone—multiple sclerosis	6.87e-05	0.00193	CcSEcCtD
Adenosine—Nausea—Cladribine—multiple sclerosis	6.86e-05	0.00193	CcSEcCtD
Adenosine—Syncope—Prednisolone—multiple sclerosis	6.84e-05	0.00193	CcSEcCtD
Adenosine—Paraesthesia—Mitoxantrone—multiple sclerosis	6.82e-05	0.00192	CcSEcCtD
Adenosine—Back pain—Triamcinolone—multiple sclerosis	6.79e-05	0.00191	CcSEcCtD
Adenosine—Dyspnoea—Mitoxantrone—multiple sclerosis	6.77e-05	0.00191	CcSEcCtD
Adenosine—Somnolence—Mitoxantrone—multiple sclerosis	6.75e-05	0.0019	CcSEcCtD
Adenosine—Loss of consciousness—Prednisolone—multiple sclerosis	6.71e-05	0.00189	CcSEcCtD
Adenosine—Convulsion—Prednisolone—multiple sclerosis	6.61e-05	0.00186	CcSEcCtD
Adenosine—Hypertension—Prednisolone—multiple sclerosis	6.59e-05	0.00185	CcSEcCtD
Adenosine—Arrhythmia—Dexamethasone—multiple sclerosis	6.53e-05	0.00184	CcSEcCtD
Adenosine—Arrhythmia—Betamethasone—multiple sclerosis	6.53e-05	0.00184	CcSEcCtD
Adenosine—Pain—Mitoxantrone—multiple sclerosis	6.49e-05	0.00183	CcSEcCtD
Adenosine—Bradycardia—Prednisone—multiple sclerosis	6.48e-05	0.00183	CcSEcCtD
Adenosine—Discomfort—Prednisolone—multiple sclerosis	6.42e-05	0.00181	CcSEcCtD
Adenosine—Angioedema—Triamcinolone—multiple sclerosis	6.41e-05	0.0018	CcSEcCtD
Adenosine—Angioedema—Methylprednisolone—multiple sclerosis	6.4e-05	0.0018	CcSEcCtD
Adenosine—Abdominal discomfort—Methotrexate—multiple sclerosis	6.37e-05	0.00179	CcSEcCtD
Adenosine—Syncope—Triamcinolone—multiple sclerosis	6.29e-05	0.00177	CcSEcCtD
Adenosine—Syncope—Methylprednisolone—multiple sclerosis	6.28e-05	0.00177	CcSEcCtD
Adenosine—Anaphylactic shock—Prednisolone—multiple sclerosis	6.23e-05	0.00175	CcSEcCtD
Adenosine—Dizziness—Azathioprine—multiple sclerosis	6.21e-05	0.00175	CcSEcCtD
Adenosine—Loss of consciousness—Triamcinolone—multiple sclerosis	6.17e-05	0.00174	CcSEcCtD
Adenosine—Loss of consciousness—Methylprednisolone—multiple sclerosis	6.15e-05	0.00173	CcSEcCtD
Adenosine—Shock—Prednisolone—multiple sclerosis	6.13e-05	0.00172	CcSEcCtD
Adenosine—Cough—Triamcinolone—multiple sclerosis	6.12e-05	0.00172	CcSEcCtD
Adenosine—Convulsion—Triamcinolone—multiple sclerosis	6.08e-05	0.00171	CcSEcCtD
Adenosine—Tachycardia—Prednisolone—multiple sclerosis	6.08e-05	0.00171	CcSEcCtD
Adenosine—Convulsion—Methylprednisolone—multiple sclerosis	6.07e-05	0.00171	CcSEcCtD
Adenosine—Hypertension—Triamcinolone—multiple sclerosis	6.06e-05	0.00171	CcSEcCtD
Adenosine—Hypertension—Methylprednisolone—multiple sclerosis	6.04e-05	0.0017	CcSEcCtD
Adenosine—Urticaria—Mitoxantrone—multiple sclerosis	6.03e-05	0.0017	CcSEcCtD
Adenosine—Hyperhidrosis—Prednisolone—multiple sclerosis	6.02e-05	0.00169	CcSEcCtD
Adenosine—Vomiting—Azathioprine—multiple sclerosis	5.97e-05	0.00168	CcSEcCtD
Adenosine—Anxiety—Methylprednisolone—multiple sclerosis	5.94e-05	0.00167	CcSEcCtD
Adenosine—Drowsiness—Methotrexate—multiple sclerosis	5.93e-05	0.00167	CcSEcCtD
Adenosine—Rash—Azathioprine—multiple sclerosis	5.92e-05	0.00167	CcSEcCtD
Adenosine—Dermatitis—Azathioprine—multiple sclerosis	5.91e-05	0.00167	CcSEcCtD
Adenosine—Flushing—Prednisone—multiple sclerosis	5.91e-05	0.00166	CcSEcCtD
Adenosine—Discomfort—Triamcinolone—multiple sclerosis	5.9e-05	0.00166	CcSEcCtD
Adenosine—Discomfort—Methylprednisolone—multiple sclerosis	5.89e-05	0.00166	CcSEcCtD
Adenosine—Headache—Azathioprine—multiple sclerosis	5.88e-05	0.00166	CcSEcCtD
Adenosine—Dry mouth—Triamcinolone—multiple sclerosis	5.84e-05	0.00164	CcSEcCtD
Adenosine—Angioedema—Dexamethasone—multiple sclerosis	5.82e-05	0.00164	CcSEcCtD
Adenosine—Angioedema—Betamethasone—multiple sclerosis	5.82e-05	0.00164	CcSEcCtD
Adenosine—Anaphylactic shock—Triamcinolone—multiple sclerosis	5.73e-05	0.00161	CcSEcCtD
Adenosine—Anaphylactic shock—Methylprednisolone—multiple sclerosis	5.71e-05	0.00161	CcSEcCtD
Adenosine—Syncope—Dexamethasone—multiple sclerosis	5.71e-05	0.00161	CcSEcCtD
Adenosine—Syncope—Betamethasone—multiple sclerosis	5.71e-05	0.00161	CcSEcCtD
Adenosine—Arrhythmia—Prednisone—multiple sclerosis	5.69e-05	0.0016	CcSEcCtD
Adenosine—Sweating—Methotrexate—multiple sclerosis	5.68e-05	0.0016	CcSEcCtD
Adenosine—Shock—Triamcinolone—multiple sclerosis	5.63e-05	0.00159	CcSEcCtD
Adenosine—Shock—Methylprednisolone—multiple sclerosis	5.62e-05	0.00158	CcSEcCtD
Adenosine—Loss of consciousness—Dexamethasone—multiple sclerosis	5.6e-05	0.00158	CcSEcCtD
Adenosine—Loss of consciousness—Betamethasone—multiple sclerosis	5.6e-05	0.00158	CcSEcCtD
Adenosine—Hypersensitivity—Mitoxantrone—multiple sclerosis	5.59e-05	0.00157	CcSEcCtD
Adenosine—Paraesthesia—Prednisolone—multiple sclerosis	5.59e-05	0.00157	CcSEcCtD
Adenosine—Tachycardia—Triamcinolone—multiple sclerosis	5.59e-05	0.00157	CcSEcCtD
Adenosine—Nausea—Azathioprine—multiple sclerosis	5.58e-05	0.00157	CcSEcCtD
Adenosine—Tachycardia—Methylprednisolone—multiple sclerosis	5.58e-05	0.00157	CcSEcCtD
Adenosine—Hyperhidrosis—Triamcinolone—multiple sclerosis	5.54e-05	0.00156	CcSEcCtD
Adenosine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	5.52e-05	0.00155	CcSEcCtD
Adenosine—Convulsion—Betamethasone—multiple sclerosis	5.52e-05	0.00155	CcSEcCtD
Adenosine—Convulsion—Dexamethasone—multiple sclerosis	5.52e-05	0.00155	CcSEcCtD
Adenosine—Hypertension—Dexamethasone—multiple sclerosis	5.5e-05	0.00155	CcSEcCtD
Adenosine—Hypertension—Betamethasone—multiple sclerosis	5.5e-05	0.00155	CcSEcCtD
Adenosine—Asthenia—Mitoxantrone—multiple sclerosis	5.45e-05	0.00153	CcSEcCtD
Adenosine—Anxiety—Betamethasone—multiple sclerosis	5.4e-05	0.00152	CcSEcCtD
Adenosine—Anxiety—Dexamethasone—multiple sclerosis	5.4e-05	0.00152	CcSEcCtD
Adenosine—Discomfort—Dexamethasone—multiple sclerosis	5.35e-05	0.00151	CcSEcCtD
Adenosine—Discomfort—Betamethasone—multiple sclerosis	5.35e-05	0.00151	CcSEcCtD
Adenosine—Hypotension—Methylprednisolone—multiple sclerosis	5.34e-05	0.0015	CcSEcCtD
Adenosine—Pain—Prednisolone—multiple sclerosis	5.32e-05	0.0015	CcSEcCtD
Adenosine—Vision blurred—Prednisone—multiple sclerosis	5.22e-05	0.00147	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	5.22e-05	0.00147	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	5.21e-05	0.00147	CcSEcCtD
Adenosine—Anaphylactic shock—Dexamethasone—multiple sclerosis	5.2e-05	0.00146	CcSEcCtD
Adenosine—Anaphylactic shock—Betamethasone—multiple sclerosis	5.2e-05	0.00146	CcSEcCtD
Adenosine—Paraesthesia—Triamcinolone—multiple sclerosis	5.14e-05	0.00145	CcSEcCtD
Adenosine—Paraesthesia—Methylprednisolone—multiple sclerosis	5.13e-05	0.00144	CcSEcCtD
Adenosine—Shock—Betamethasone—multiple sclerosis	5.11e-05	0.00144	CcSEcCtD
Adenosine—Shock—Dexamethasone—multiple sclerosis	5.11e-05	0.00144	CcSEcCtD
Adenosine—Dyspnoea—Triamcinolone—multiple sclerosis	5.11e-05	0.00144	CcSEcCtD
Adenosine—Agitation—Prednisone—multiple sclerosis	5.09e-05	0.00143	CcSEcCtD
Adenosine—Tachycardia—Betamethasone—multiple sclerosis	5.07e-05	0.00143	CcSEcCtD
Adenosine—Tachycardia—Dexamethasone—multiple sclerosis	5.07e-05	0.00143	CcSEcCtD
Adenosine—Angioedema—Prednisone—multiple sclerosis	5.07e-05	0.00143	CcSEcCtD
Adenosine—Hyperhidrosis—Betamethasone—multiple sclerosis	5.02e-05	0.00141	CcSEcCtD
Adenosine—Hyperhidrosis—Dexamethasone—multiple sclerosis	5.02e-05	0.00141	CcSEcCtD
Adenosine—Syncope—Prednisone—multiple sclerosis	4.97e-05	0.0014	CcSEcCtD
Adenosine—Tinnitus—Methotrexate—multiple sclerosis	4.96e-05	0.0014	CcSEcCtD
Adenosine—Urticaria—Prednisolone—multiple sclerosis	4.95e-05	0.00139	CcSEcCtD
Adenosine—Cardiac disorder—Methotrexate—multiple sclerosis	4.94e-05	0.00139	CcSEcCtD
Adenosine—Pain—Triamcinolone—multiple sclerosis	4.9e-05	0.00138	CcSEcCtD
Adenosine—Loss of consciousness—Prednisone—multiple sclerosis	4.87e-05	0.00137	CcSEcCtD
Adenosine—Hypotension—Betamethasone—multiple sclerosis	4.86e-05	0.00137	CcSEcCtD
Adenosine—Hypotension—Dexamethasone—multiple sclerosis	4.86e-05	0.00137	CcSEcCtD
Adenosine—Vomiting—Mitoxantrone—multiple sclerosis	4.83e-05	0.00136	CcSEcCtD
Adenosine—Convulsion—Prednisone—multiple sclerosis	4.8e-05	0.00135	CcSEcCtD
Adenosine—Mediastinal disorder—Methotrexate—multiple sclerosis	4.8e-05	0.00135	CcSEcCtD
Adenosine—Hypertension—Prednisone—multiple sclerosis	4.79e-05	0.00135	CcSEcCtD
Adenosine—Rash—Mitoxantrone—multiple sclerosis	4.79e-05	0.00135	CcSEcCtD
Adenosine—Dermatitis—Mitoxantrone—multiple sclerosis	4.78e-05	0.00135	CcSEcCtD
Adenosine—Headache—Mitoxantrone—multiple sclerosis	4.75e-05	0.00134	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	4.73e-05	0.00133	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	4.73e-05	0.00133	CcSEcCtD
Adenosine—Anxiety—Prednisone—multiple sclerosis	4.7e-05	0.00132	CcSEcCtD
Adenosine—Paraesthesia—Dexamethasone—multiple sclerosis	4.67e-05	0.00131	CcSEcCtD
Adenosine—Paraesthesia—Betamethasone—multiple sclerosis	4.67e-05	0.00131	CcSEcCtD
Adenosine—Discomfort—Prednisone—multiple sclerosis	4.66e-05	0.00131	CcSEcCtD
Adenosine—Hypersensitivity—Prednisolone—multiple sclerosis	4.59e-05	0.00129	CcSEcCtD
Adenosine—Urticaria—Triamcinolone—multiple sclerosis	4.55e-05	0.00128	CcSEcCtD
Adenosine—Urticaria—Methylprednisolone—multiple sclerosis	4.54e-05	0.00128	CcSEcCtD
Adenosine—Dysgeusia—Methotrexate—multiple sclerosis	4.54e-05	0.00128	CcSEcCtD
Adenosine—Anaphylactic shock—Prednisone—multiple sclerosis	4.52e-05	0.00127	CcSEcCtD
Adenosine—Nausea—Mitoxantrone—multiple sclerosis	4.51e-05	0.00127	CcSEcCtD
Adenosine—Back pain—Methotrexate—multiple sclerosis	4.48e-05	0.00126	CcSEcCtD
Adenosine—Shock—Prednisone—multiple sclerosis	4.45e-05	0.00125	CcSEcCtD
Adenosine—Pain—Dexamethasone—multiple sclerosis	4.44e-05	0.00125	CcSEcCtD
Adenosine—Pain—Betamethasone—multiple sclerosis	4.44e-05	0.00125	CcSEcCtD
Adenosine—Tachycardia—Prednisone—multiple sclerosis	4.42e-05	0.00124	CcSEcCtD
Adenosine—Hyperhidrosis—Prednisone—multiple sclerosis	4.37e-05	0.00123	CcSEcCtD
Adenosine—Vision blurred—Methotrexate—multiple sclerosis	4.37e-05	0.00123	CcSEcCtD
Adenosine—Hypersensitivity—Triamcinolone—multiple sclerosis	4.22e-05	0.00119	CcSEcCtD
Adenosine—Hypersensitivity—Methylprednisolone—multiple sclerosis	4.21e-05	0.00119	CcSEcCtD
Adenosine—Urticaria—Betamethasone—multiple sclerosis	4.13e-05	0.00116	CcSEcCtD
Adenosine—Urticaria—Dexamethasone—multiple sclerosis	4.13e-05	0.00116	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Prednisone—multiple sclerosis	4.12e-05	0.00116	CcSEcCtD
Adenosine—Dizziness—Prednisolone—multiple sclerosis	4.12e-05	0.00116	CcSEcCtD
Adenosine—Asthenia—Triamcinolone—multiple sclerosis	4.11e-05	0.00116	CcSEcCtD
Adenosine—Asthenia—Methylprednisolone—multiple sclerosis	4.1e-05	0.00115	CcSEcCtD
Adenosine—Paraesthesia—Prednisone—multiple sclerosis	4.06e-05	0.00114	CcSEcCtD
Adenosine—Cough—Methotrexate—multiple sclerosis	4.04e-05	0.00114	CcSEcCtD
Adenosine—Convulsion—Methotrexate—multiple sclerosis	4.01e-05	0.00113	CcSEcCtD
Adenosine—Chest pain—Methotrexate—multiple sclerosis	3.94e-05	0.00111	CcSEcCtD
Adenosine—Rash—Prednisolone—multiple sclerosis	3.93e-05	0.00111	CcSEcCtD
Adenosine—Dermatitis—Prednisolone—multiple sclerosis	3.92e-05	0.0011	CcSEcCtD
Adenosine—Headache—Prednisolone—multiple sclerosis	3.9e-05	0.0011	CcSEcCtD
Adenosine—Discomfort—Methotrexate—multiple sclerosis	3.9e-05	0.0011	CcSEcCtD
Adenosine—Dizziness—Triamcinolone—multiple sclerosis	3.79e-05	0.00107	CcSEcCtD
Adenosine—Anaphylactic shock—Methotrexate—multiple sclerosis	3.78e-05	0.00106	CcSEcCtD
Adenosine—Dizziness—Methylprednisolone—multiple sclerosis	3.78e-05	0.00106	CcSEcCtD
Adenosine—Asthenia—Dexamethasone—multiple sclerosis	3.73e-05	0.00105	CcSEcCtD
Adenosine—Asthenia—Betamethasone—multiple sclerosis	3.73e-05	0.00105	CcSEcCtD
Adenosine—Nausea—Prednisolone—multiple sclerosis	3.7e-05	0.00104	CcSEcCtD
Adenosine—Hyperhidrosis—Methotrexate—multiple sclerosis	3.66e-05	0.00103	CcSEcCtD
Adenosine—Vomiting—Triamcinolone—multiple sclerosis	3.64e-05	0.00103	CcSEcCtD
Adenosine—Vomiting—Methylprednisolone—multiple sclerosis	3.63e-05	0.00102	CcSEcCtD
Adenosine—Rash—Triamcinolone—multiple sclerosis	3.61e-05	0.00102	CcSEcCtD
Adenosine—Dermatitis—Triamcinolone—multiple sclerosis	3.61e-05	0.00102	CcSEcCtD
Adenosine—Rash—Methylprednisolone—multiple sclerosis	3.6e-05	0.00101	CcSEcCtD
Adenosine—Dermatitis—Methylprednisolone—multiple sclerosis	3.6e-05	0.00101	CcSEcCtD
Adenosine—Urticaria—Prednisone—multiple sclerosis	3.59e-05	0.00101	CcSEcCtD
Adenosine—Headache—Triamcinolone—multiple sclerosis	3.59e-05	0.00101	CcSEcCtD
Adenosine—Headache—Methylprednisolone—multiple sclerosis	3.58e-05	0.00101	CcSEcCtD
Adenosine—Hypotension—Methotrexate—multiple sclerosis	3.53e-05	0.000995	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	3.45e-05	0.00097	CcSEcCtD
Adenosine—Dizziness—Dexamethasone—multiple sclerosis	3.44e-05	0.000967	CcSEcCtD
Adenosine—Dizziness—Betamethasone—multiple sclerosis	3.44e-05	0.000967	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—CXCL13—multiple sclerosis	3.41e-05	0.0022	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CNR1—multiple sclerosis	3.41e-05	0.00219	CbGpPWpGaD
Adenosine—Nausea—Triamcinolone—multiple sclerosis	3.4e-05	0.000958	CcSEcCtD
Adenosine—Paraesthesia—Methotrexate—multiple sclerosis	3.4e-05	0.000956	CcSEcCtD
Adenosine—Nausea—Methylprednisolone—multiple sclerosis	3.39e-05	0.000955	CcSEcCtD
Adenosine—Dyspnoea—Methotrexate—multiple sclerosis	3.37e-05	0.000949	CcSEcCtD
Adenosine—ADORA2A—Circadian rythm related genes—FAS—multiple sclerosis	3.37e-05	0.00216	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CNR1—multiple sclerosis	3.36e-05	0.00216	CbGpPWpGaD
Adenosine—Somnolence—Methotrexate—multiple sclerosis	3.36e-05	0.000946	CcSEcCtD
Adenosine—ADORA1—Signaling by GPCR—RGS1—multiple sclerosis	3.35e-05	0.00215	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—S1PR1—multiple sclerosis	3.35e-05	0.00215	CbGpPWpGaD
Adenosine—Hypersensitivity—Prednisone—multiple sclerosis	3.33e-05	0.000939	CcSEcCtD
Adenosine—Vomiting—Dexamethasone—multiple sclerosis	3.3e-05	0.00093	CcSEcCtD
Adenosine—Vomiting—Betamethasone—multiple sclerosis	3.3e-05	0.00093	CcSEcCtD
Adenosine—Rash—Dexamethasone—multiple sclerosis	3.28e-05	0.000922	CcSEcCtD
Adenosine—Rash—Betamethasone—multiple sclerosis	3.28e-05	0.000922	CcSEcCtD
Adenosine—Dermatitis—Dexamethasone—multiple sclerosis	3.27e-05	0.000921	CcSEcCtD
Adenosine—Dermatitis—Betamethasone—multiple sclerosis	3.27e-05	0.000921	CcSEcCtD
Adenosine—Headache—Betamethasone—multiple sclerosis	3.25e-05	0.000916	CcSEcCtD
Adenosine—Headache—Dexamethasone—multiple sclerosis	3.25e-05	0.000916	CcSEcCtD
Adenosine—Asthenia—Prednisone—multiple sclerosis	3.25e-05	0.000914	CcSEcCtD
Adenosine—Pain—Methotrexate—multiple sclerosis	3.23e-05	0.00091	CcSEcCtD
Adenosine—ADORA1—GPCR downstream signaling—CXCL13—multiple sclerosis	3.2e-05	0.00206	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CCR1—multiple sclerosis	3.2e-05	0.00206	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—GPR65—multiple sclerosis	3.17e-05	0.00204	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TAGAP—multiple sclerosis	3.13e-05	0.00201	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CCL3—multiple sclerosis	3.11e-05	0.002	CbGpPWpGaD
Adenosine—Nausea—Betamethasone—multiple sclerosis	3.09e-05	0.000869	CcSEcCtD
Adenosine—Nausea—Dexamethasone—multiple sclerosis	3.09e-05	0.000869	CcSEcCtD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	3.09e-05	0.00198	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL10—multiple sclerosis	3.07e-05	0.00198	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—LINGO1—multiple sclerosis	3.07e-05	0.00197	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CCL5—multiple sclerosis	3.07e-05	0.00197	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—S1PR1—multiple sclerosis	3.04e-05	0.00196	CbGpPWpGaD
Adenosine—ADORA1—G alpha (i) signalling events—POMC—multiple sclerosis	3.03e-05	0.00195	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CXCL10—multiple sclerosis	3.03e-05	0.00195	CbGpPWpGaD
Adenosine—ADA—Metabolism—RRM1—multiple sclerosis	3.02e-05	0.00194	CbGpPWpGaD
Adenosine—Urticaria—Methotrexate—multiple sclerosis	3e-05	0.000846	CcSEcCtD
Adenosine—ADORA2A—GPCR ligand binding—PTGER4—multiple sclerosis	3e-05	0.00193	CbGpPWpGaD
Adenosine—Dizziness—Prednisone—multiple sclerosis	2.99e-05	0.000842	CcSEcCtD
Adenosine—ADORA1—Signaling by GPCR—CCR1—multiple sclerosis	2.9e-05	0.00187	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCL13—multiple sclerosis	2.9e-05	0.00187	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CXCR3—multiple sclerosis	2.89e-05	0.00186	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—CD86—multiple sclerosis	2.89e-05	0.00186	CbGpPWpGaD
Adenosine—Vomiting—Prednisone—multiple sclerosis	2.88e-05	0.00081	CcSEcCtD
Adenosine—Rash—Prednisone—multiple sclerosis	2.85e-05	0.000803	CcSEcCtD
Adenosine—Dermatitis—Prednisone—multiple sclerosis	2.85e-05	0.000802	CcSEcCtD
Adenosine—ADORA2A—GPCR downstream signaling—RGS1—multiple sclerosis	2.85e-05	0.00183	CbGpPWpGaD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	2.84e-05	0.00182	CbGpPWpGaD
Adenosine—Headache—Prednisone—multiple sclerosis	2.83e-05	0.000798	CcSEcCtD
Adenosine—ADORA2A—GPCR ligand binding—CCR2—multiple sclerosis	2.82e-05	0.00181	CbGpPWpGaD
Adenosine—Hypersensitivity—Methotrexate—multiple sclerosis	2.79e-05	0.000784	CcSEcCtD
Adenosine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	2.78e-05	0.00179	CbGpPWpGaD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.77e-05	0.00178	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CCR5—multiple sclerosis	2.76e-05	0.00178	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—CD80—multiple sclerosis	2.74e-05	0.00176	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—S1PR1—multiple sclerosis	2.74e-05	0.00176	CbGpPWpGaD
Adenosine—Asthenia—Methotrexate—multiple sclerosis	2.71e-05	0.000764	CcSEcCtD
Adenosine—ADORA2A—GPCR downstream signaling—GPR65—multiple sclerosis	2.7e-05	0.00174	CbGpPWpGaD
Adenosine—Nausea—Prednisone—multiple sclerosis	2.69e-05	0.000757	CcSEcCtD
Adenosine—ADORA2B—Signaling Pathways—GPC5—multiple sclerosis	2.66e-05	0.00171	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TAGAP—multiple sclerosis	2.66e-05	0.00171	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	2.64e-05	0.0017	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CCL5—multiple sclerosis	2.61e-05	0.00168	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CNR1—multiple sclerosis	2.6e-05	0.00167	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—RGS1—multiple sclerosis	2.59e-05	0.00166	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—PTGER4—multiple sclerosis	2.58e-05	0.00166	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—ALB—multiple sclerosis	2.56e-05	0.00165	CbGpPWpGaD
Adenosine—ADK—Metabolism—BCHE—multiple sclerosis	2.55e-05	0.00164	CbGpPWpGaD
Adenosine—Dizziness—Methotrexate—multiple sclerosis	2.5e-05	0.000704	CcSEcCtD
Adenosine—ADORA2B—GPCR downstream signaling—CXCR3—multiple sclerosis	2.49e-05	0.0016	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCL13—multiple sclerosis	2.47e-05	0.00159	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CCR1—multiple sclerosis	2.47e-05	0.00159	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—GPR65—multiple sclerosis	2.45e-05	0.00158	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CCL3—multiple sclerosis	2.43e-05	0.00156	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CCR2—multiple sclerosis	2.42e-05	0.00156	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	2.41e-05	0.00155	CbGpPWpGaD
Adenosine—Vomiting—Methotrexate—multiple sclerosis	2.4e-05	0.000677	CcSEcCtD
Adenosine—Rash—Methotrexate—multiple sclerosis	2.38e-05	0.000671	CcSEcCtD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	2.38e-05	0.00153	CbGpPWpGaD
Adenosine—Dermatitis—Methotrexate—multiple sclerosis	2.38e-05	0.000671	CcSEcCtD
Adenosine—ADORA2A—Signaling Pathways—LINGO1—multiple sclerosis	2.37e-05	0.00152	CbGpPWpGaD
Adenosine—Headache—Methotrexate—multiple sclerosis	2.37e-05	0.000667	CcSEcCtD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	2.36e-05	0.00152	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CCR5—multiple sclerosis	2.35e-05	0.00151	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—PTGER4—multiple sclerosis	2.34e-05	0.00151	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CXCL10—multiple sclerosis	2.34e-05	0.0015	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—S1PR1—multiple sclerosis	2.33e-05	0.0015	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—RGS1—multiple sclerosis	2.33e-05	0.0015	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—TYK2—multiple sclerosis	2.31e-05	0.00149	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GPC5—multiple sclerosis	2.26e-05	0.00146	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CXCR3—multiple sclerosis	2.26e-05	0.00145	CbGpPWpGaD
Adenosine—Nausea—Methotrexate—multiple sclerosis	2.25e-05	0.000632	CcSEcCtD
Adenosine—ADORA2A—Signaling by GPCR—CCR1—multiple sclerosis	2.24e-05	0.00144	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCL13—multiple sclerosis	2.24e-05	0.00144	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CNR1—multiple sclerosis	2.24e-05	0.00144	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—GPR65—multiple sclerosis	2.21e-05	0.00142	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CCR2—multiple sclerosis	2.2e-05	0.00142	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—PTGER4—multiple sclerosis	2.19e-05	0.00141	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—POMC—multiple sclerosis	2.16e-05	0.00139	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CXCR3—multiple sclerosis	2.12e-05	0.00136	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CCL2—multiple sclerosis	2.11e-05	0.00136	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—CD80—multiple sclerosis	2.11e-05	0.00135	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—POMC—multiple sclerosis	2.08e-05	0.00134	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCL3—multiple sclerosis	2.07e-05	0.00133	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CCR2—multiple sclerosis	2.06e-05	0.00132	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TAGAP—multiple sclerosis	2.06e-05	0.00132	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—CCL2—multiple sclerosis	2.04e-05	0.00131	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CNR1—multiple sclerosis	2.03e-05	0.00131	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCL13—multiple sclerosis	2.02e-05	0.0013	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCR1—multiple sclerosis	2.02e-05	0.0013	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CCL5—multiple sclerosis	2.01e-05	0.00129	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CXCL10—multiple sclerosis	2.01e-05	0.00129	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—IL6—multiple sclerosis	2.01e-05	0.00129	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—PTGER4—multiple sclerosis	1.99e-05	0.00128	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—RGS1—multiple sclerosis	1.98e-05	0.00127	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCR3—multiple sclerosis	1.92e-05	0.00124	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CNR1—multiple sclerosis	1.9e-05	0.00122	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—GPR65—multiple sclerosis	1.88e-05	0.00121	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCR2—multiple sclerosis	1.87e-05	0.0012	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	1.86e-05	0.0012	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—POMC—multiple sclerosis	1.84e-05	0.00118	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CXCL10—multiple sclerosis	1.83e-05	0.00118	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	1.82e-05	0.00117	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CCR5—multiple sclerosis	1.81e-05	0.00117	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CCL2—multiple sclerosis	1.8e-05	0.00116	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—S1PR1—multiple sclerosis	1.8e-05	0.00116	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—TYK2—multiple sclerosis	1.78e-05	0.00114	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GPC5—multiple sclerosis	1.75e-05	0.00112	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CCL5—multiple sclerosis	1.73e-05	0.00111	CbGpPWpGaD
Adenosine—ADA—Metabolism—BCHE—multiple sclerosis	1.73e-05	0.00111	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CNR1—multiple sclerosis	1.73e-05	0.00111	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCR1—multiple sclerosis	1.72e-05	0.0011	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCL13—multiple sclerosis	1.72e-05	0.0011	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CXCL10—multiple sclerosis	1.71e-05	0.0011	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—PTGER4—multiple sclerosis	1.69e-05	0.00109	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCR3—multiple sclerosis	1.64e-05	0.00105	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—STAT3—multiple sclerosis	1.62e-05	0.00104	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCL3—multiple sclerosis	1.6e-05	0.00103	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CCR2—multiple sclerosis	1.59e-05	0.00102	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CCL5—multiple sclerosis	1.57e-05	0.00101	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CCR5—multiple sclerosis	1.56e-05	0.001	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCL10—multiple sclerosis	1.55e-05	0.001	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—IL2RA—multiple sclerosis	1.54e-05	0.00099	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—PTGER4—multiple sclerosis	1.54e-05	0.000989	CbGpPWpGaD
Adenosine—ADK—Metabolism—APOE—multiple sclerosis	1.53e-05	0.000985	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—RGS1—multiple sclerosis	1.53e-05	0.000982	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—IL6—multiple sclerosis	1.49e-05	0.00096	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCR3—multiple sclerosis	1.49e-05	0.000955	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CCL5—multiple sclerosis	1.47e-05	0.000948	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—MAPK1—multiple sclerosis	1.47e-05	0.000946	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CNR1—multiple sclerosis	1.47e-05	0.000944	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—GPR65—multiple sclerosis	1.45e-05	0.000931	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCR2—multiple sclerosis	1.44e-05	0.000929	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCL3—multiple sclerosis	1.44e-05	0.000924	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CCR5—multiple sclerosis	1.42e-05	0.000912	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—POMC—multiple sclerosis	1.42e-05	0.000912	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL2RA—multiple sclerosis	1.4e-05	0.000899	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CCL2—multiple sclerosis	1.39e-05	0.000892	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PTGER4—multiple sclerosis	1.38e-05	0.00089	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—PGR—multiple sclerosis	1.36e-05	0.000876	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCL5—multiple sclerosis	1.34e-05	0.000861	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCR3—multiple sclerosis	1.34e-05	0.000859	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CNR1—multiple sclerosis	1.33e-05	0.000857	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CCR5—multiple sclerosis	1.33e-05	0.000854	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL13—multiple sclerosis	1.32e-05	0.000852	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCR1—multiple sclerosis	1.32e-05	0.000852	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CD28—multiple sclerosis	1.32e-05	0.000851	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCL10—multiple sclerosis	1.32e-05	0.00085	CbGpPWpGaD
Adenosine—ADK—Metabolism—POMC—multiple sclerosis	1.32e-05	0.000847	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—IL2RA—multiple sclerosis	1.31e-05	0.000841	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCR2—multiple sclerosis	1.3e-05	0.000836	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—STAT3—multiple sclerosis	1.24e-05	0.0008	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCL3—multiple sclerosis	1.22e-05	0.000786	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—POMC—multiple sclerosis	1.22e-05	0.000785	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCR5—multiple sclerosis	1.21e-05	0.000775	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCL10—multiple sclerosis	1.2e-05	0.000772	CbGpPWpGaD
Adenosine—ADK—Metabolism—ALB—multiple sclerosis	1.2e-05	0.000772	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CNR1—multiple sclerosis	1.2e-05	0.000771	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL2RA—multiple sclerosis	1.19e-05	0.000764	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PTGER4—multiple sclerosis	1.18e-05	0.000757	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—PGR—multiple sclerosis	1.16e-05	0.000745	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—IL6—multiple sclerosis	1.15e-05	0.000741	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CCL5—multiple sclerosis	1.14e-05	0.000732	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCR3—multiple sclerosis	1.14e-05	0.000731	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—MAPK1—multiple sclerosis	1.13e-05	0.000728	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—multiple sclerosis	1.13e-05	0.000727	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CD28—multiple sclerosis	1.13e-05	0.000724	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—POMC—multiple sclerosis	1.11e-05	0.000713	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCR2—multiple sclerosis	1.11e-05	0.000711	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CCL2—multiple sclerosis	1.08e-05	0.000697	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCL10—multiple sclerosis	1.08e-05	0.000695	CbGpPWpGaD
Adenosine—ADA—Metabolism—APOE—multiple sclerosis	1.04e-05	0.00067	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—POMC—multiple sclerosis	1.04e-05	0.000667	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCL5—multiple sclerosis	1.03e-05	0.000664	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CCR5—multiple sclerosis	1.03e-05	0.000659	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CNR1—multiple sclerosis	1.02e-05	0.000656	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—IL2RA—multiple sclerosis	1.01e-05	0.00065	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—TYK2—multiple sclerosis	9.85e-06	0.000633	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CD86—multiple sclerosis	9.45e-06	0.000607	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCL3—multiple sclerosis	9.44e-06	0.000607	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—POMC—multiple sclerosis	9.42e-06	0.000606	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCR5—multiple sclerosis	9.31e-06	0.000599	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCL5—multiple sclerosis	9.3e-06	0.000598	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCL2—multiple sclerosis	9.22e-06	0.000593	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCL10—multiple sclerosis	9.18e-06	0.000591	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL2RA—multiple sclerosis	9.17e-06	0.00059	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PTGER4—multiple sclerosis	9.08e-06	0.000584	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—IL2—multiple sclerosis	9.02e-06	0.00058	CbGpPWpGaD
Adenosine—ADA—Metabolism—POMC—multiple sclerosis	8.95e-06	0.000575	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—PGR—multiple sclerosis	8.95e-06	0.000575	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCR3—multiple sclerosis	8.77e-06	0.000564	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—IL6—multiple sclerosis	8.7e-06	0.000559	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CD28—multiple sclerosis	8.69e-06	0.000559	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—SPP1—multiple sclerosis	8.61e-06	0.000554	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCR2—multiple sclerosis	8.53e-06	0.000549	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCR5—multiple sclerosis	8.38e-06	0.000539	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—TYK2—multiple sclerosis	8.37e-06	0.000538	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL2RA—multiple sclerosis	8.26e-06	0.000531	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL2—multiple sclerosis	8.19e-06	0.000527	CbGpPWpGaD
Adenosine—ADA—Metabolism—ALB—multiple sclerosis	8.16e-06	0.000525	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CD86—multiple sclerosis	8.03e-06	0.000516	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—POMC—multiple sclerosis	8.01e-06	0.000515	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCL5—multiple sclerosis	7.91e-06	0.000508	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CNR1—multiple sclerosis	7.88e-06	0.000506	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—IL2—multiple sclerosis	7.67e-06	0.000493	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—APOE—multiple sclerosis	7.62e-06	0.00049	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—SPP1—multiple sclerosis	7.32e-06	0.000471	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—POMC—multiple sclerosis	7.28e-06	0.000468	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCR5—multiple sclerosis	7.12e-06	0.000458	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCL2—multiple sclerosis	7.12e-06	0.000458	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL10—multiple sclerosis	7.09e-06	0.000456	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL2RA—multiple sclerosis	7.02e-06	0.000451	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL2—multiple sclerosis	6.97e-06	0.000448	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CD80—multiple sclerosis	6.89e-06	0.000443	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—POMC—multiple sclerosis	6.55e-06	0.000421	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—APOE—multiple sclerosis	6.48e-06	0.000417	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—TYK2—multiple sclerosis	6.46e-06	0.000416	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCL2—multiple sclerosis	6.41e-06	0.000412	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—MAPK1—multiple sclerosis	6.27e-06	0.000403	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CD86—multiple sclerosis	6.2e-06	0.000399	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCL5—multiple sclerosis	6.1e-06	0.000393	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—IL2—multiple sclerosis	5.92e-06	0.000381	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CD80—multiple sclerosis	5.86e-06	0.000377	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TYK2—multiple sclerosis	5.82e-06	0.000374	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—SPP1—multiple sclerosis	5.65e-06	0.000364	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—POMC—multiple sclerosis	5.57e-06	0.000358	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCR5—multiple sclerosis	5.5e-06	0.000354	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCL2—multiple sclerosis	5.45e-06	0.00035	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL2RA—multiple sclerosis	5.42e-06	0.000349	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL2—multiple sclerosis	5.38e-06	0.000346	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—MAPK1—multiple sclerosis	5.33e-06	0.000343	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—APOE—multiple sclerosis	5e-06	0.000322	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TYK2—multiple sclerosis	4.95e-06	0.000318	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL2—multiple sclerosis	4.84e-06	0.000311	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6—multiple sclerosis	4.82e-06	0.00031	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MMP9—multiple sclerosis	4.58e-06	0.000295	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CD80—multiple sclerosis	4.52e-06	0.000291	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—POMC—multiple sclerosis	4.3e-06	0.000276	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCL2—multiple sclerosis	4.21e-06	0.00027	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL2—multiple sclerosis	4.12e-06	0.000265	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—MAPK1—multiple sclerosis	4.11e-06	0.000265	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6—multiple sclerosis	4.09e-06	0.000263	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—STAT3—multiple sclerosis	4.07e-06	0.000262	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MMP9—multiple sclerosis	3.89e-06	0.00025	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TYK2—multiple sclerosis	3.82e-06	0.000246	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MYC—multiple sclerosis	3.78e-06	0.000243	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—TGFB1—multiple sclerosis	3.78e-06	0.000243	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—MAPK1—multiple sclerosis	3.7e-06	0.000238	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—STAT3—multiple sclerosis	3.46e-06	0.000223	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MYC—multiple sclerosis	3.22e-06	0.000207	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—TGFB1—multiple sclerosis	3.21e-06	0.000206	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL2—multiple sclerosis	3.18e-06	0.000204	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6—multiple sclerosis	3.16e-06	0.000203	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—MAPK1—multiple sclerosis	3.15e-06	0.000202	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MMP9—multiple sclerosis	3.01e-06	0.000193	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6—multiple sclerosis	2.84e-06	0.000183	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—STAT3—multiple sclerosis	2.67e-06	0.000172	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MYC—multiple sclerosis	2.48e-06	0.00016	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—TGFB1—multiple sclerosis	2.48e-06	0.000159	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—MAPK1—multiple sclerosis	2.43e-06	0.000156	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6—multiple sclerosis	2.42e-06	0.000156	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6—multiple sclerosis	1.87e-06	0.00012	CbGpPWpGaD
